Carl Walkley

Hudson Institute of Medical Research

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Maya Kansara

Head, Translational Oncology Lab

Garvan Institute of Medical Research

AUSTRALIA

View details

Yan Xu

University of Miyazaki

JAPAN

View details

Miguel Fidalgo

Associate Professor

Universidade de Santiago de Compostela

SPAIN

View details

Shifeng Xue

National University of Singapore (NUS)

SINGAPORE

View details

Luciano Martelotto

A/Professor, Head of the Development Laboratory

University of Adelaide

AUSTRALIA

View details

Katharine Floyd

Emory University

UNITED STATES

View details

Jacki Heraud-Farlow

University of Melbourne

AUSTRALIA

View details

Alistair Chalk

St Vincent's Institute of Medical Research

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carl Walkley

Research Interests

Explore related searches

Contact this professor

Articles (13)

Special Issue: RNA and Hematology

Leveraging genetics to understand ADAR1-mediated RNA editing in health and disease

A-to-I RNA Editing and Hematopoiesis

GGNBP2 regulates MDA5 sensing triggered by self double-stranded RNA following loss of ADAR1 editing

Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2.

The phenotype of the most common human ADAR1p150 Zα mutation P193A in mice is partially penetrant

Over-expression of ADAR1 in mice does not initiate or accelerate cancer formation in vivo

Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype.

ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation.

Generation of a new Adar1p150 mouse demonstrates isoform-specific roles in embryonic development and adult homeostasis.

Direct identification of A-to-I editing sites with nanopore native RNA sequencing.

Srsf2P95H/+ co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in mice

ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis

Collaborators (8)

Maya Kansara

Yan Xu

Miguel Fidalgo

Shifeng Xue

Luciano Martelotto

Katharine Floyd

Jacki Heraud-Farlow

Alistair Chalk

Make your next move.